Liquid Dosage
As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.
GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.
In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.
GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.
Affichage de 4 sur 8

GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.

GEA Hilge offre une gamme polyvalente de pompes centrifuges et de pompes volumétriques positives pour un large éventail d’applications sensibles dans les industries des boissons, agroalimentaire et pharmaceutique.

GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.

Les concepts NEP innovants de GEA répondent à des normes strictes et complètes. Nos experts garantissent la sûreté du produit à chaque étape du processus. Chaque mise à niveau est adaptée aux conditions locales particulières et aux exigences du client, et permet de réaliser des économies notables.
GEA’s past fiscal year was one of significant growth and further profitability gains. In particular, the technology group substantially increased order intake, with all divisions contributing here. GEA also made progress in all Mission 30 strategic growth areas. In addition, GEA met key interim targets under its climate plan ahead of schedule. Major milestones in fiscal year 2025 were admission to the DAX index, the award of one of the largest contracts in the company’s history, and streamlining of the corporate structure.
Grâce à un nouveau site de fabrication, le SmartParc, des transformateurs de produits alimentaires du Royaume-Uni diminuent leurs dépenses courantes et leurs émissions. S'appuyant sur la technologie de chauffage et de refroidissement de GEA, ce modèle de production collaboratif démontre comment l'innovation accélère les ambitions « zéro net » de l'industrie.
« Brasser des œufs, c'est comme brasser de la bière. » C'est le genre de comparaison qui fait sourire, puis qui fait tilt : Quelque chose qui semblait complexe devient soudain simple. Dans ce film personnel, qui se déroule dans le cœur agricole des États-Unis, nous explorons la fermentation de précision et le travail concret qu'il faut accomplir pour transformer une idée en nourriture.